G.Barekat Pharm (XTEH:BRKT1) Scaled Net Operating Assets : N/A (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

G.Barekat Pharm's operating assets for the quarter that ended in Mar. 2017 was IRR30,996,924 Mil. G.Barekat Pharm's operating liabilities for the quarter that ended in Mar. 2017 was IRR13,682,337 Mil. G.Barekat Pharm's Total Assets for the quarter that ended in Mar. 2016 was IRR0 Mil. Therefore, G.Barekat Pharm's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2017 was N/A.

G.Barekat Pharm Scaled Net Operating Assets Historical Data

The historical data trend for G.Barekat Pharm's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Scaled Net Operating Assets Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Scaled Net Operating Assets

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Scaled Net Operating Assets	-	-

Competitive Comparison of G.Barekat Pharm's Scaled Net Operating Assets

For the Biotechnology subindustry, G.Barekat Pharm's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Scaled Net Operating Assets falls into.

G.Barekat Pharm Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

G.Barekat Pharm's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2017 )
=	(Operating Assets (A: Mar. 2017 )	-	Operating Liabilities (A: Mar. 2017 ))	/	Total Assets (A: Mar. 2016 )
=	(30996924	-	13682337)	/	0
=	N/A

where

	Operating Assets		(A: Mar. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	34818314	-	3821390
=	30996924

	Operating Liabilities		(A: Mar. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	24253612	-	255897	-	10315378
=	13682337

G.Barekat Pharm's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2017 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Mar. 2017 )
=	(Operating Assets (Q: Mar. 2017 )	-	Operating Liabilities (Q: Mar. 2017 ))	/	Total Assets (Q: Mar. 2016 )
=	(30996924	-	13682337)	/	0
=	N/A

where

	Operating Assets		(Q: Mar. 2017 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	34818314	-	3821390
=	30996924

	Operating Liabilities		(Q: Mar. 2017 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	24253612	-	255897	-	10315378
=	13682337

G.Barekat Pharm Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines